Loading...
Loading...
shares touched a new 52-week low of $0.63 on discontinuation of fispemifene in secondary hypogonadism.
SunOpta, Inc. (USA) STKL shares reached a new 52-week low of $4.31. SunOpta shares have tumbled 58.07 percent over the past 52 weeks, while the S&P 500 index has dropped 1.22 percent in the same period.
Portola Pharmaceuticals IncPTLA shares touched a new 52-week low of $18.66. Goldman Sachs downgraded Portola Pharmaceuticals from Buy to Neutral and lowered the price target from $65.00 to $30.00.
H & R Block IncHRB shares dropped 1.09 percent to touch a new 52-week low of $26.32. H & R Block shares have declined 16.92 percent over the past 52 weeks, while the S&P 500 index has dropped 1.22 percent in the same period.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in